Soluble Biomarkers
Customised biomarker panels to enhance all stages of therapeutic development.
- Services
- Soluble Biomarkers
Innovative Biomarker Solutions for Clinical Research
Synexa Life Sciences has over two decades experience designing biomarker strategies to support customers’ broader clinical development objectives. Our team of scientists are experts in finding the optimum analytical strategy for biomarker selection, analysis and data interpretation.
Synexa’s global setup aims to support research programs from translational research through to late-stage clinical trials and post-marketing surveillance. Working collaboratively, we focus on careful selection of markers to ensure results that support decision-making and a significant return on investment.
Our Specialised Biomarker Services Include:
- Advice on the optimal selection of biomarker in the context of the drug, disease and budget
- Development, optimisation and validation of biomarker assays across a wide range of matrices and technology platforms
- Biomarker analysis of clinical samples for exploratory or clinical trial settings
Biomarker Solutions
Protein
- AlphaLISA
- CBA
- DELFIA
- ELISA & ELISpot
- Fluorescence and luminescence-based assays
- Gyrolab
- MesoScale
- Nephelometry
- Olink
- Radioimmunoassays
DNA
- Digital PCR (dPCR)
- Electrophoresis
- Pharmacogenetics
- Targeted Sequencing
RNA
- Gene expression array
- NanoString
- RT-qPCR
Cell
- Cell Culture Assays
- Circulating Tumor Cells (CTC)
- Flow Cytometry
- Fluorescence Microscopy
- Microbiology
- Sorting
Tissue
- Correlative Light and Electron Microscopy (CLEM)
- Multiplex Immunofluorescence
- Organotypic culture
- Super Resolution Microscopy
- Whole Tissue Analysis
The Scientific Partner of Choice for Biomarker and Bioanalytical Solutions
Bridging the gap between science and life.